Literature DB >> 24170579

Malnutrition in cystic fibrosis: a review.

Suzanne Culhane1, Carolyn George, Brittany Pearo, Elizabeth Spoede.   

Abstract

Malnutrition is one of the main burdens of disease in cystic fibrosis (CF) along with lung disease. Data from the most recent Cystic Fibrosis Foundation registry report show the prevalence of malnutrition is decreasing in the CF population primarily from interventions focusing on preventing malnutrition. Despite success of interventions and decreased prevalence of malnutrition in this population, prevention of malnutrition in CF patients remains a dilemma that must be managed throughout the life cycle. The pathogenesis of malnutrition in CF can be further categorized into 3 main areas: increased energy losses, increased energy needs, and inadequate calorie intake. The purpose of this review is to further explore the causes of malnutrition and explain current research to prevent malnutrition in the CF population.

Entities:  

Keywords:  cystic fibrosis; liver diseases; lung diseases; nutritional status; pancreas; pancreatic diseases

Mesh:

Year:  2013        PMID: 24170579     DOI: 10.1177/0884533613507086

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  21 in total

1.  Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.

Authors:  Tasma Harindhanavudhi; Qi Wang; Jordan Dunitz; Antoinette Moran; Amir Moheet
Journal:  J Cyst Fibros       Date:  2019-11-11       Impact factor: 5.482

2.  Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)-associated Bronchiectasis: Role of RA-related Autoantibodies.

Authors:  Gregory McDermott; Ritu Gill; Staci Gagne; Suzanne Byrne; Weixing Huang; Xiaosong Wang; Lauren C Prisco; Alessandra Zaccardelli; Lily W Martin; Lucy Masto; Vanessa L Kronzer; Nancy Shadick; Paul F Dellaripa; Tracy J Doyle; Jeffrey A Sparks
Journal:  J Rheumatol       Date:  2022-03-15       Impact factor: 5.346

3.  Low body mass index as a barrier to lung transplant in cystic fibrosis.

Authors:  Ann L Jennerich; Joseph B Pryor; Travis Y Hee Wai; Siddhartha G Kapnadak; Moira L Aitken; Christopher H Goss; Kathleen J Ramos
Journal:  J Cyst Fibros       Date:  2021-12-23       Impact factor: 5.527

4.  Evaluation of Malnutrition Risk in Lung Transplant Candidates Using the Nutritional Risk Index.

Authors:  Karan Chohan; Jeff Park; Sarah Dales; Rhea Varughese; Lisa Wickerson; Lianne G Singer; Brooke Stewart; Dmitry Rozenberg
Journal:  Transplant Direct       Date:  2020-06-23

5.  Melanocortin 3 receptor has a 5' exon that directs translation of apically localized protein from the second in-frame ATG.

Authors:  Jeenah Park; Neeraj Sharma; Garry R Cutting
Journal:  Mol Endocrinol       Date:  2014-07-22

6.  Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.

Authors:  Kathleen J Ramos; Siddhartha G Kapnadak; Miranda C Bradford; Ranjani Somayaji; Eric D Morrell; Joseph M Pilewski; Erika D Lease; Michael S Mulligan; Moira L Aitken; Cynthia J Gries; Christopher H Goss
Journal:  Chest       Date:  2020-01-17       Impact factor: 9.410

Review 7.  Pathobiology of frailty in lung disease.

Authors:  Brittany Koons; John R Greenland; Joshua M Diamond; Jonathan P Singer
Journal:  Transl Res       Date:  2020-05-03       Impact factor: 7.012

8.  Nutritional status and lung transplantation: an intriguing problem.

Authors:  Mario Nosotti; Michele Ferrari
Journal:  Ann Transl Med       Date:  2020-02

9.  Real-World Evidence of Treatment, Tolerance, Healthcare Utilization, and Costs Among Postacute Care Adult Patients Receiving Enteral Peptide-Based Diets in the United States.

Authors:  Chris LaVallee; Prafullakumar Seelam; Santosh Balakrishnan; Cynthia Lowen; Aimee Henrikson; Bill Kesting; Moreno Perugini; Krysmaru Araujo Torres
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-03-18       Impact factor: 3.896

10.  Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis.

Authors:  Michael S Schechter; Suzanne Michel; Shufang Liu; B Woun Seo; Mudra Kapoor; Rupal Khurmi; Mark Haupt
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-10       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.